iTonic Holdings Ltd Dossier - Source-backed chat

iTonic Holdings Ltd

ITOCNASDAQ

SectorHealth Care

IndustryMedical Devices

Beta (adjusted)2.18

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.28Price as of 30 Sep 2026

Data confidence Sign in to view data confidence

Market Cap $6.9M

Shares Outstanding 24.7M diluted

Next Earnings Date19 Oct 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

iTonic Holdings Ltd (formerly Pheton Holdings Ltd) is a micro-cap healthcare technology company specializing in brachytherapy treatment planning systems (TPS). While the company successfully secured $20 million in gross proceeds through a private placement in April 2026 to fund its AI-powered cloud healthcare platform, it faces severe near-term delisting risks. The stock has been trading significantly below the Nasdaq minimum bid price of $1.00, with an extension granted only until October 19, 2026. Given the high volatility, ongoing net losses, and regulatory compliance hurdles, a 'Hold' recommendation is advised until the company demonstrates a clear path to maintaining its Nasdaq listing and commercializing its AI platform.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets0 analysts

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$0.1020%

The company fails to regain compliance with the Nasdaq Minimum Bid Price Rule by October 19, 2026, and is subsequently delisted to the OTC markets. Investor confidence deteriorates, liquidity dries up, and the six-month lock-up expiration on the 100 million private placement shares in October 2026 triggers severe downward price pressure.

Base CaseCentral scenario

$0.3055%

iTonic Holdings struggles to organically lift its share price above $1.00 and is forced to execute a reverse stock split to maintain its Nasdaq listing before the October 19, 2026 deadline. Development of the AI-powered cloud platform continues slowly, with high R&D expenses keeping the company in a net loss position.

Bull CaseUpside scenario

$1.0025%

The company successfully leverages its $20 million private placement capital to accelerate the development and commercialization of its AI-enabled TPS Cloud Platform. It regains Nasdaq compliance through a successful reverse stock split or organic price recovery, establishing its technology as a new standard of care in brachytherapy across global markets.

Scenarios reflect our research view at the research date.

Key Investment Merits

Secured $20 million in gross funding through an April 2026 private placement, providing substantial runway for product development.
Active development of an innovative AI-enabled Treatment Planning System (TPS) Cloud Platform designed to support nuclear medicine and digital care delivery.
Niche focus on brachytherapy, a targeted radiation therapy with high clinical significance in cancer treatment.

Key Investment Risks

Imminent risk of Nasdaq delisting if the closing bid price does not reach $1.00 by October 19, 2026.
History of net losses (-$5.1M for FY2025) and a previously disclosed going concern warning.
Potential dilution and selling pressure following the expiration of the six-month lock-up period for the 100 million Class A shares issued in April 2026.
Frequent board and independent director transitions, which may impact corporate governance stability.

Thesis Invalidation Triggers

Receipt of an official Nasdaq delisting determination notice.
Failure to release or achieve regulatory clearance for the AI-enabled TPS Cloud Platform.
Unexpected depletion of the $20 million cash reserve without corresponding revenue generation.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.